Standout Papers
Citation Impact
Citing Papers
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
2009 Standout
Chemoprophylaxis of scrapie in mice
1991
Leukocytes, the Janus cells in inflammatory disease
1999
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
2006
Exercise Standards for Testing and Training
2013 Standout
Day–Night Pattern of Sudden Death in Obstructive Sleep Apnea
2005
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea
2005
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Insoluble wild–type and protease–resistant mutant prion protein in brains of patients with inherited prion disease
1996 StandoutNobel
Knocking down barriers: advances in siRNA delivery
2009 Standout
Practice Parameters for the Indications for Polysomnography and Related Procedures: An Update for 2005
2005 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Can ethnopharmacology contribute to the development of antiviral drugs?
1991
Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro
1982 StandoutNobel
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
2006
Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virus
1982 StandoutNobel
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Antiviral Activity of Carbobenzoxy Di- and Tripeptides on Measles Virus
1968
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies.
1993 StandoutNobel
Sleep Apnea and Cardiovascular Disease
2008
9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group
1978 StandoutNatureNobel
Combined antiviral effect of DNA inhibitors onHerpes simplex virus multiplication
1980
Species differences in the disposition of acyclovir
1982 StandoutNobel
Novel Methods and Devices to Enhance Transdermal Drug Delivery: the Importance of Laser Radiation in Transdermal Drug Delivery
2012
Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection
1980
Defective interfering particles of poliovirus
1973 StandoutNobel
Sleep Apnea and Cardiovascular Disease
2008
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Defective interfering particles of poliovirus
1973 StandoutNobel
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Identification of small DNA fragments synthesized in herpes simplex virus-infected cells in the presence of acyclovir
1984 StandoutNobel
The chemotherapeutic exploitation of virus-specified enzymes
1980 StandoutNobel
Specific Inhibition of Replication of Animal Viruses
1963 Science
Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro
1980
Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
1978 StandoutNobel
The Purine Path to Chemotherapy
1989 ScienceNobel
Plant Products as Antimicrobial Agents
1999 Standout
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
2000 Standout
Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate
1979 StandoutNobel
Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice
1979 StandoutNobel
Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function.
1981 StandoutNobel
Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus
1982 StandoutNobel
In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine
1992
Pathophysiology of Sleep Apnea
2010 Standout
In vitro susceptibility of varicella-zoster virus to acyclovir
1980 StandoutNobel
Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines
1981 StandoutNobel
Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice
1982 StandoutNobel
A new method for the synthesis of some 9-β--arabinofuranosylpurines by a combination of chemical and enzymatic reactions
1980
Treatment of experimental herpes simplex keratitis with acycloguanosine.
1979
The Mononuclear Molybdenum Enzymes
2014 Standout
An enzymic synthesis of purine d-Arabinonucleosides
1981 StandoutNobel
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
1977 StandoutNobel
Mechanism of action and selectivity of acyclovir
1982 StandoutNobel
RELATIVE POTENCIES OF ANTI‐HERPES COMPOUNDS
1977
Synthesis of Heterocycles from Alkyl 3-(Dimethylamino)propenoates and Related Enaminones
2004 Standout
Effect of acyclovir on various murine in vivo and in vitro immunologic assay systems
1982 StandoutNobel
Metabolism of acyclovir in virus-infected and uninfected cells
1981 StandoutNobel
Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir
1980 StandoutNobel
Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication
1980 StandoutNobel
Synthesis of Alkyl 1-(Substituted Pyridin-2-yl)-1H-1,2,3-triazole-4-carboxylates by ‘Ring Switching’ Transformation of 4-Oxo-4H-pyridino[1,2-a]pyrimidine-3-diazonium Tetrafluoroborates
2000
Works of Dirk Bauer being referenced
Clinical Significance of Sleep‐Related Breathing Disorders in Patients with Implantable Cardioverter Defibrillators
1999
Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense
2005
Sleep-Related Breathing Disorders Are Associated With Ventricular Arrhythmias in Patients With an Implantable Cardioverter-Defibrillator
2002
BIOLOGICAL ACTIVITIES OF SOME PURINE ARABINOSIDES
1975 StandoutNobel
A HISTORY OF THE DISCOVERY AND CLINICAL APPLICATION OF ANTIVIRAL DRUGS
1985
NEW ANTIVIRAL CHEMOTHERAPEUTIC AGENT ACTIVE AGAINST SMALLPOX INFECTION
1960
A novel method for detecting the antiviral activity of flavans in their vapour phase
1983
The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent
1979
CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1‐METHYLISATIN 3‐THIOSEMICARBAZONE) *
1965
Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines
2005
Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties
1985
Analysis of leukocyte activation during acute rejection of pulmonary allografts in noninfected and cytomegalovirus-infected rats
1997
Topical Treatment with Antisense Oligonucleotides Targeting Tumor Necrosis Factor-α in Herpetic Stromal Keratitis
2003
Comparison of activity of herpes virus inhibitors
1977